Company Overview
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through two segments, Reinforcement Materials and Performance Chemicals. The company offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions. It also provides specialty carbons for use in inks, coatings, plastics, adhesives, toners, batteries, and displays; conductive additives and fumed alumina used in lead acid and lithium-ion batteries for electric vehicles; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; and fumed alumina for use in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries. In addition, it offers aerogel, a hydrophobic, silica-based particle to use in various thermal insulation and specialty chemical applications; masterbatch and conductive compound products that are used in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; and inkjet colorants for inkjet printing applications, as well as carbon nanotubes and fumed metal oxides. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.
Why Investors Should Care
Generates a return on equity of 20.0%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 21.7%.
Trades at a P/E of 17.0, below the sector median of 23.1.
Operating margin of 15.3% supports profitability.
Offers a dividend yield of 2.10%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Sep 2025 Revenue of $3.71B (-7.0% YoY); net profit $331.00M.
- Trailing 12 Months Year-on-year growth — revenue -3.4%, earnings -24.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 0.9%, profit CAGR 8.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 0.90% |
| 1 Year: | -3.40% |
Compounded Profit Growth
| 5 Years: | 8.25% |
| 1 Year: | -24.90% |
Stock Price Performance
| 1 Year: | +18.28% |
| 6 Months: | +24.39% |
| 3 Months: | +21.13% |
| 1 Month: | +2.50% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)56.11 · Neutral
P/E of 16.98 is below the sector median of 23.08 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Healthy ROCE of 21.7%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CBT Cabot Corporation R2K | 89.84 | 16.98 | $4.64B | 2.10% | 21.73% | 19.96% | 0.90% | 8.25% |
| 2 | LIN Linde plc NDXSPX | 514.15 | 34.05 | $237.72B | 1.22% | 12.46% | 18.23% | 13.90% | 18.47% |
| 3 | NEM Newmont Corporation SPX | 95.21 | 12.35 | $101.64B | 1.10% | - | 25.83% | 6.53% | 20.15% |
| 4 | FCX Freeport-McMoRan Inc. SPX | 60.97 | 32.26 | $87.65B | 0.97% | 12.50% | 15.63% | 1.35% | -1.26% |
| 5 | SHW The Sherwin-Williams Company SPX | 332.29 | 31.92 | $81.95B | 0.97% | 21.93% | 60.72% | 6.18% | 8.26% |
| 6 | ECL Ecolab Inc. SPX | 270.25 | 36.57 | $76.06B | 1.07% | 14.29% | 22.43% | 6.17% | 9.18% |
| 7 | CRH CRH plc SPX | 103.96 | 19.04 | $69.47B | 1.52% | 10.97% | 15.81% | 6.41% | 9.30% |
| 8 | APD Air Products and Chemicals, Inc. SPX | 293.69 | 30.98 | $65.40B | 2.40% | -0.62% | 12.35% | -1.77% | -39.16% |
| 9 | CTVA Corteva, Inc. SPX | 84.45 | 46.15 | $56.48B | 0.84% | - | 5.14% | 2.86% | 9.94% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 694.00M | 694.00M | 671.00M | 603.00M | 568.00M | 621.00M | 619.00M | 611.00M | 678.00M | 705.00M | 723.00M | 720.00M | 818.00M | 854.00M | 850.00M | 821.00M | 844.00M | 845.00M | 827.00M | 727.00M | 710.00M | 518.00M | 659.00M | 746.00M | 842.00M | 917.00M | 968.00M | 1.09B | 1.15B | 965.00M | 1.03B | 968.00M | 958.00M | 1.02B | 1.02B | 955.00M | 936.00M | 923.00M | 849.00M | 904.00M |
| Gross Profit | 139.00M | 150.00M | 139.00M | 99.00M | 150.00M | 160.00M | 169.00M | 159.00M | 169.00M | 161.00M | 174.00M | 176.00M | 188.00M | 197.00M | 211.00M | 166.00M | 178.00M | 170.00M | 171.00M | 141.00M | 153.00M | 69.00M | 137.00M | 193.00M | 214.00M | 214.00M | 198.00M | 232.00M | 235.00M | 181.00M | 210.00M | 223.00M | 218.00M | 246.00M | 256.00M | 235.00M | 241.00M | 244.00M | 211.00M | 210.00M |
| Operating Income | 54.00M | -494.00M | - | 12.00M | 77.00M | 83.00M | - | 84.00M | 90.00M | 84.00M | - | 91.00M | -161.00M | 106.00M | - | 77.00M | 73.00M | 81.00M | - | 63.00M | 24.00M | 4.00M | - | 118.00M | 128.00M | 134.00M | -83.00M | 161.00M | 168.00M | 105.00M | 129.00M | 150.00M | 136.00M | 156.00M | 172.00M | 155.00M | 162.00M | 167.00M | 129.00M | 129.00M |
| Net Income | 26.00M | -445.00M | 40.00M | -7.00M | 48.00M | 56.00M | 52.00M | 55.00M | 74.00M | 47.00M | 72.00M | -122.00M | -173.00M | 88.00M | 94.00M | 69.00M | 23.00M | 32.00M | 33.00M | 41.00M | -1.00M | -6.00M | -272.00M | 60.00M | 75.00M | 86.00M | -89.00M | 107.00M | 97.00M | 54.00M | 75.00M | 82.00M | 50.00M | 84.00M | 109.00M | 93.00M | 94.00M | 101.00M | 73.00M | 68.00M |
| Diluted EPS | 0.41 | -7.04 | 0.63 | -0.11 | 0.76 | 0.88 | 0.83 | 0.86 | 1.19 | 0.73 | 1.13 | -1.98 | -2.80 | 1.40 | 1.51 | 1.14 | 0.39 | 0.55 | 0.55 | 0.70 | -0.01 | -0.12 | -4.81 | 1.06 | 1.30 | 1.48 | -1.57 | 1.84 | 1.69 | 0.93 | 1.29 | 1.43 | 0.88 | 1.49 | 1.94 | 1.67 | 1.69 | 1.86 | 1.37 | 1.27 |
| R&D Expense | 14.00M | 15.00M | - | 16.00M | 11.00M | 13.00M | - | 12.00M | 14.00M | 14.00M | - | 15.00M | 16.00M | 17.00M | - | 16.00M | 15.00M | 16.00M | - | 14.00M | 14.00M | 13.00M | - | 14.00M | 15.00M | 12.00M | 13.00M | 14.00M | 14.00M | 13.00M | 15.00M | 15.00M | 15.00M | 15.00M | 16.00M | 14.00M | 15.00M | 15.00M | 13.00M | 14.00M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Sep 2008 | Sep 2009 | Sep 2010 | Sep 2011 | Sep 2012 | Sep 2013 | Sep 2014 | Sep 2015 | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.19B | 2.11B | 2.72B | 3.10B | 3.29B | 3.46B | 3.65B | 2.87B | 2.41B | 2.72B | 3.24B | 3.34B | 2.61B | 3.41B | 4.32B | 3.93B | 3.99B | 3.71B |
| Gross Profit | 484.00M | 217.00M | 510.00M | 558.00M | 644.00M | 633.00M | 721.00M | 585.00M | 575.00M | 657.00M | 772.00M | 685.00M | 500.00M | 799.00M | 885.00M | 839.00M | 960.00M | 940.00M |
| Operating Income | 164.00M | -54.00M | 204.00M | 243.00M | 291.00M | 268.00M | 335.00M | -317.00M | 247.00M | 338.00M | 144.00M | 306.00M | 21.00M | 454.00M | 389.00M | 526.00M | 614.00M | 621.00M |
| Net Income | 86.00M | -77.00M | 154.00M | 236.00M | 388.00M | 153.00M | 199.00M | -334.00M | 147.00M | 248.00M | -113.00M | 157.00M | -238.00M | 250.00M | 209.00M | 445.00M | 380.00M | 331.00M |
| Diluted EPS | 1.32 | -1.25 | 2.35 | 3.57 | 5.99 | 2.36 | 3.03 | -5.27 | 2.32 | 3.91 | -1.85 | 2.63 | -4.21 | 4.34 | 3.62 | 7.73 | 6.72 | 6.02 |
| R&D Expense | 74.00M | 66.00M | 65.00M | 66.00M | 72.00M | 68.00M | 60.00M | 58.00M | 53.00M | 57.00M | 66.00M | 60.00M | 57.00M | 56.00M | 55.00M | 57.00M | 63.00M | 59.00M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Sep 2007 | Sep 2008 | Sep 2009 | Sep 2010 | Sep 2011 | Sep 2012 | Sep 2013 | Sep 2014 | Sep 2015 | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 2.68B | 2.89B | 3.14B | 4.40B | 4.23B | 4.08B | 3.06B | 3.05B | 3.34B | 3.24B | 3.00B | 2.78B | - | 3.52B | 3.60B | 3.74B | 3.81B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.82B | 1.63B | 1.60B | 1.54B |
| Cash & Equivalents | 154.00M | 129.00M | 304.00M | 387.00M | 286.00M | 120.00M | 95.00M | 67.00M | 77.00M | 200.00M | 280.00M | 175.00M | 169.00M | 151.00M | - | 206.00M | 238.00M | 223.00M | 258.00M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 664.00M | 585.00M | 552.00M | 504.00M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 836.00M | 695.00M | 733.00M | 671.00M |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.49B | 2.20B | 2.15B | 2.11B |
| Current Liabilities | - | - | 477.00M | 539.00M | 656.00M | 919.00M | 844.00M | 630.00M | 441.00M | 397.00M | 742.00M | 952.00M | 599.00M | 529.00M | - | 1.10B | 822.00M | 772.00M | 957.00M |
| Long Term Debt | - | - | 623.00M | 600.00M | 556.00M | 1.17B | 1.02B | 1.00B | 970.00M | 914.00M | 661.00M | 719.00M | 1.02B | 1.09B | - | 1.09B | 1.09B | 1.09B | 856.00M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.53B | 1.36B | 1.23B | 1.22B |
| Total Equity | 1.27B | 1.36B | 1.13B | 1.30B | 1.49B | 1.81B | 1.95B | 1.94B | 1.23B | 1.27B | 1.50B | 1.15B | 998.00M | 691.00M | - | 898.00M | 1.26B | 1.43B | 1.55B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 56.39M | 55.38M | 54.43M | 52.96M |
Cash Flows (Annual)
Figures in USD.
| Metric | Sep 2008 | Sep 2009 | Sep 2010 | Sep 2011 | Sep 2012 | Sep 2013 | Sep 2014 | Sep 2015 | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 124.00M | 399.00M | 249.00M | 195.00M | 415.00M | 419.00M | 315.00M | 499.00M | 392.00M | 348.00M | 298.00M | 363.00M | 377.00M | 257.00M | 100.00M | 595.00M | 692.00M | 665.00M |
| Investing Cash Flow | -176.00M | -105.00M | -112.00M | -232.00M | -1.18B | -227.00M | -16.00M | -162.00M | -104.00M | -149.00M | -246.00M | -94.00M | -288.00M | -186.00M | -118.00M | -214.00M | -235.00M | -298.00M |
| Financing Cash Flow | 23.00M | -127.00M | -57.00M | -72.00M | 606.00M | -206.00M | -302.00M | -256.00M | -184.00M | -133.00M | -141.00M | -236.00M | -132.00M | -60.00M | 145.00M | -403.00M | -415.00M | -336.00M |
| Capital Expenditure | -199.00M | -106.00M | -108.00M | -230.00M | -281.00M | -264.00M | -171.00M | -141.00M | -112.00M | -147.00M | -229.00M | -224.00M | -200.00M | -195.00M | -211.00M | -244.00M | -241.00M | -274.00M |
| Free Cash Flow | -75.00M | 293.00M | 141.00M | -35.00M | 134.00M | 155.00M | 144.00M | 358.00M | 280.00M | 201.00M | 69.00M | 139.00M | 177.00M | 62.00M | -111.00M | 351.00M | 451.00M | 391.00M |
| Share Buybacks | 35.00M | 2.00M | 5.00M | 59.00M | 36.00M | 6.00M | 18.00M | 101.00M | 45.00M | 61.00M | 142.00M | 173.00M | 44.00M | 3.00M | 53.00M | 98.00M | 172.00M | 168.00M |
Ratios (Annual)
Figures in %.
| Metric | Sep 2008 | Sep 2009 | Sep 2010 | Sep 2011 | Sep 2012 | Sep 2013 | Sep 2014 | Sep 2015 | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 15.2% | 10.3% | 18.8% | 18.0% | 19.6% | 18.3% | 19.8% | 20.4% | 23.8% | 24.2% | 23.8% | 20.5% | 19.1% | 23.4% | 20.5% | 21.3% | 24.0% | 25.3% |
| Operating Margin % | 5.1% | -2.6% | 7.5% | 7.8% | 8.8% | 7.8% | 9.2% | -11.0% | 10.2% | 12.4% | 4.4% | 9.2% | 0.8% | 13.3% | 9.0% | 13.4% | 15.4% | 16.7% |
| Net Margin % | 2.7% | -3.7% | 5.7% | 7.6% | 11.8% | 4.4% | 5.5% | -11.6% | 6.1% | 9.1% | -3.5% | 4.7% | -9.1% | 7.3% | 4.8% | 11.3% | 9.5% | 8.9% |
| ROE % | 6.3% | -6.8% | 11.8% | 15.9% | 21.4% | 7.8% | 10.2% | -27.1% | 11.5% | 16.5% | -9.8% | 15.7% | -34.4% | - | 23.3% | 35.2% | 26.7% | 21.4% |
| ROCE % | - | -2.5% | 8.7% | 9.8% | 8.4% | 7.9% | 9.7% | -12.1% | 9.3% | 13.0% | 6.3% | 12.7% | 0.9% | - | 16.1% | 18.9% | 20.7% | 21.7% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 12.82% | 6.62M | $580.49M |
| 2 | Wellington Management Group, LLP | 6.91% | 3.57M | $312.90M |
| 3 | Earnest Partners LLC | 6.12% | 3.16M | $277.14M |
| 4 | Vanguard Portfolio Management LLC | 6.05% | 3.12M | $273.87M |
| 5 | Vanguard Capital Management LLC | 4.50% | 2.32M | $203.93M |
| 6 | American Century Companies Inc | 4.33% | 2.24M | $196.32M |
| 7 | Fuller & Thaler Asset Management Inc. | 3.97% | 2.05M | $179.71M |
| 8 | State Street Corporation | 3.93% | 2.03M | $177.88M |
| 9 | Dimensional Fund Advisors LP | 3.38% | 1.74M | $152.91M |
| 10 | Bank of America Corporation | 2.94% | 1.52M | $133.03M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CBT
Is Cabot (CBT) Using Steady Dividends To Redefine Its Battery Materials Investment Story? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxQNS1sVFJsZWtxX0F3b3NEYVNHRWZsLUhpTVl0RDRfY3dzYVdjUzI2aUtuMENjS3ZaQXJXam5EM3N1dFdLWTVESjdHVnJkaE9vQXlFM0VOVmYzSjJndzRWeENyc0NhdlRpV2k3ekt1M0tONjExeHJNWm11RmVzX1l3TWtHc1BNMWQ0T250OD…
Cabot (NYSE:CBT) Shares Cross Above 200 Day Moving Average - Here's What Happened - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxQNk1uX01URmlRWUxrOFBESkZuMTNjYXdUZXprN2NranBIdEE1ZF82MmdNMzdvWDNKbkVFUXFpUGVoOWs2U056YVJmRkU3LUpwWUZGU2diQVUyR1J4LU5rbnV5NWRPNUpfYzhBVXdvSHFkM3V2Q2I0NFByd245dmVJVndfSlR0WTJXLUZFVF…
Here's Why You Should Retain Cabot Stock in Your Portfolio for Now - TradingView
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxNZ0RSZFRISU5saXVBTEMyWGVwNUlpQWtJS1pZdktkamZGbS1ad2FsNkZ6UzVFNDlId3Y2QS03QjdQVHJZUmFaaFc0VDNtblpFd2lOcFlrQ0NLZ3JhNnRXbkx2M3pGRFRSVF94ejdvZTU3UFdnS0d1eEUtQk1nVWtFZzlDZzNCMUEwZnFnby…
CBT Stock Price, Quote & Chart - ChartMill
<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE9KdUhSaHY3NzNzMTYtRW1NeGJIN290YWJnRHl3OHZYdzNXQ3V4dFpkemRhd0RwMHZRMnVXTGx5cFM3SV90clFtbnlqUTJGY3RDajlPTFd2S3REamZjQVE?oc=5" target="_blank">CBT Stock Price, Quote & Chart</a> …
Is Cabot Corporation (CBT) A Good Stock To Buy Now? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQd2FrclJhV3RnMmdkR0ZlaEJSR2Y4cm5IT1RMNWwzU0xuT0FSVGUxdDlDNldwQVVoVXBDRWtpOVkzQ3daN3hsSExqek5id2NBLTR2anVYbTN6ZlJDb29neHo2aDBxaGlmM1BXQ3VERW5ZclAzbUtiT0dWY0Rhbkl1N2I0R1RycTlFMGJyYz…
Cabot schedules Aug. 3 results release and Aug. 4 webcast - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNaEpSWVphd3BxQUtQeEN4cnYwbWhmM05MSDZRT19Mbl9fazhWZzk5MWdfMmxyRmMzSjkwdWRpUURQM0VIdzI3TnR2ZldHc1FKNy1vM1prQ2pieERxcUpWanlQQURBSHR3SkVVT0ZlWGZaX0Vab2xvQk1scS12eVpHVXlUbXJiY1hSdVVjY1…
CBT — Frequently Asked Questions
What is the current share price of Cabot Corporation (CBT)?
As of 2026-07-15 16:51 PDT, Cabot Corporation (CBT) trades at $89.84 on NYSE. Its 52-week range is $57.64 to $93.40.
What is the market capitalisation of CBT?
Cabot Corporation (CBT) has a market capitalisation of $4.64B on NYSE.
What is the P/E ratio of CBT?
CBT trades at a trailing price-to-earnings (P/E) ratio of 16.98. The industry average P/E is 23.08. Its price-to-book (P/B) ratio is 2.89.
Does CBT pay a dividend?
Cabot Corporation (CBT) currently offers a dividend yield of 2.10%.
What is the return on equity (ROE) of CBT?
CBT has a return on equity (ROE) of 19.96%. Its return on capital employed (ROCE) is 21.73%.
Is CBT a good stock to buy?
This page provides a data-driven analysis of Cabot Corporation (CBT), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.